The Wuhan Institute of virology has studied the efficacy of Shuanghuanglian

category:Society
 The Wuhan Institute of virology has studied the efficacy of Shuanghuanglian


Wuhan Virus Research Institute is a comprehensive research institution specialized in basic virology research and related technological innovation, with the only P4 level biosafety laboratory in China, and is qualified to carry out high pathogenic microorganism experiment. In 2019, the microbial (toxin) species preservation center of the Institute was designated as the national virus resource bank by the Ministry of science and technology and the Ministry of finance.

Nandu correspondent has noticed novel coronavirus pneumonia outbreak, so far, there are many discoveries in the origin, pathogen detection and drug screening of the Wuhan Virus Research Institute, for example, the virus strains were isolated in January 5th, and the first time they came up with viruses or bats.

Have jointly studied the efficacy of Shuanghuanglian

Wuhan Virus Research Institute of Chinese Academy of Sciences (hereinafter referred to as Wuhan Virus Research Institute) was founded in 1956. It is a comprehensive research institute specializing in basic virology research and related technological innovation. In January 2018, Wuhan National Biosafety (Level 4) laboratory (hereinafter referred to as Wuhan P4 laboratory) passed the assessment and was officially put into operation.

It is understood that P4 is the highest level of protection in biosafety laboratory, and it is qualified to carry out highly pathogenic pathogenic microorganism experiment. In 2019, the microbial (toxin) species preservation center of the Institute was designated as the national virus resource bank by the Ministry of science and technology and the Ministry of finance.

After the outbreak of novel coronavirus pneumonia, the Wuhan Institute of virus has been in dispute. Novel coronavirus was found in the late January 31st, the central media reported that the joint research of Shanghai Institute of Materia Medica of Chinese Academy of Sciences (hereinafter referred to as the Shanghai Institute of medicine) and the Wuhan Institute of viruses found that the Chinese patent medicine Shuanghuanglian oral liquid could inhibit the new coronavirus. The news caused many people to rush to buy, but also raised questions.

On February 1, the Shanghai Pharmaceutical Institute issued a circular saying that the articles provided to the media were accurate in content. The circular revealed that novel coronavirus was inhibited by the double coptis chinensis through laboratory in vitro tests, and the next step is to confirm it by further clinical research. However, the Wuhan Virus Research Institute, as a joint research party, did not speak out.

In February 15th, a novel coronavirus pneumonia was reported on the Internet. It is reported that novel coronavirus pneumonia is the 2019 member of the Wuhan Virus Research Institute, Huang Yanling, and she is a 2012 degree graduate student of the Wuhan Institute of virus.

In February 16th, the novel coronavirus issued by Wuhan Virus Research Institute issued a response statement: it was verified that the researchers received masters degree in 2015 after graduation. The research contents of this semester are bacteriophage lyase function and antibacterial broad-spectrum. After graduation, they have been working in other provinces and have not been back to Wuhan, and have not been infected by 2019 new coronavirus and are healthy. The statement also said that at the critical moment of anti epidemic, the rumors greatly interfered with the scientific research work of the Institute and will reserve the right to investigate legal responsibility according to law.

First mention of virus or origin bat

Since the end of last year, virus tracing, pathogen detection, drug screening The scientific and technological workers of Wuhan Virus Research Institute of Chinese Academy of sciences have been stepping up their scientific research to fight against the epidemic, never stopping for a moment. On February 11, 2020, the official wechat of the Chinese Academy of Sciences forwarded a focus: Wuhan Virus Research Institute in the great epidemic and said so.

The novel coronavirus sample collection and standardized storage work began in December 30, 2019, according to the official website of the Wuhan Institute of virus.

According to an exclusive interview with Shi Zhengli, a researcher of Wuhan Virus Research Institute, Hubei Daily said: at 10:00 p.m. on December 30, 2019, we were entrusted by Wuhan CDC to test samples of several patients..

Novel coronavirus novel coronavirus was identified by the Wuhan Institute of virus in January 2nd, and the virus strain was successfully isolated in January 5th. In January 9th, the virus resources were stored in the national virus database and standardized preservation (preservation number: IVCAS6.7512). In January 11th, the WHO submitted 2019 new coronavirus genomes to the World Health Organization (WHO). Sequence information is released in the global influenza shared database (gisaid) to realize global sharing.

Novel coronavirus novel coronavirus novel coronavirus was introduced in the bioRxiv preprint platform in January 23rd. The new virus is derived from bat. This article confirms for the first time that the new coronavirus uses the same cells as SARS coronavirus into the receptor (ACE2), and finds a new coronavirus and a bat, Shi Zhengli said. The sequence consistence of the coronavirus was as high as 96%, which provided an important basis for the follow-up study of pathogenicity mechanism and virus traceability.

(function() {(window. Slotbydup = window. Slotbydup| []). Push ({ID: u5811557, container: ssp_, async: true});}) ()); source of this paper: responsible editor of Southern Metropolis Daily: huachengyu